Abstract
Infusion of interleukin-12 (IL-12) enhances recovery from lethal experimental vesicular stomatitis virus (VSV) infection of the central nervous system (CNS). Interleukin-12 treatment resulted in: 1) increased survival frequency; 2) faster recovery from weight loss; 3) substantially decreased VSV titers in brain homogenates and diminished immunohistochemical detection of VSV antigens in tissue sections; 4) earlier and increased CNS expression of types 1, 2, and 3 nitric oxide synthase (NOS) and both major histocompatibility complex (MHC) class I and class II antigens; 5) earlier and increased blood and CNS levels of tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ). These results suggest that IL-12 enhances recovery from VSV infection of the CNS.
Original language | English (US) |
---|---|
Pages (from-to) | 35-47 |
Number of pages | 13 |
Journal | Viral Immunology |
Volume | 10 |
Issue number | 1 |
DOIs | |
State | Published - 1997 |
ASJC Scopus subject areas
- Immunology
- Molecular Medicine
- Virology